1. Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study): 36‐month follow‐up results of a clinical chart review
   Junji Yonese et al, 2023, International Journal of Urology CrossRef
2. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab
   Ryo Fujiwara et al, 2023, Nutrition and Cancer CrossRef